Study on Blood Glucose Variations in Tumor Patients Before and After Total Parenteral Nutrition
TPN
Phase 1: Select Tumor Patients to be Observed Phase 2: Observe the Blood Glucose Values During TPN Phase 3: Sort Data
1 other identifier
observational
86
1 country
1
Brief Summary
The purpose of this study is to determine the relationship among TPN, tumor and blood glucose.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 18, 2013
CompletedFirst Posted
Study publicly available on registry
December 31, 2013
CompletedDecember 31, 2013
December 1, 2013
11 months
December 18, 2013
December 27, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glycemic Variations during TPN
Observe the blood glucose variation in tumor patients after surgery. According to the TPN infusion time, the blood glucose values are divided into three parts: pre TPN, within 24h and after 24h.
1 year
Study Arms (1)
Tumor patients, TPN, surgery
This work involved prospective study of surgical patients receiving TPN during the calendar year of 2013 at Cancer Hospital.
Eligibility Criteria
Tumor patients using TPN in abdominal surgery department in Cancer Hospital.
You may qualify if:
- tumor patients,2.use TPN after surgery
You may not qualify if:
- without using TPN
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
Related Publications (2)
Pasquel FJ, Spiegelman R, McCauley M, Smiley D, Umpierrez D, Johnson R, Rhee M, Gatcliffe C, Lin E, Umpierrez E, Peng L, Umpierrez GE. Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care. 2010 Apr;33(4):739-41. doi: 10.2337/dc09-1748. Epub 2009 Dec 29.
PMID: 20040658BACKGROUNDYang JC, Dai YY, Wang LM, Xie YB, Zhou HY, Li GH. Glycemic Variation in Tumor Patients with Total Parenteral Nutrition. Chin Med J (Engl). 2015 Aug 5;128(15):2034-9. doi: 10.4103/0366-6999.161358.
PMID: 26228214DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Jincheng Yang, Doctor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- pharmacist
Study Record Dates
First Submitted
December 18, 2013
First Posted
December 31, 2013
Study Start
January 1, 2013
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
December 31, 2013
Record last verified: 2013-12